DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 51 filers reported holding DESIGN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $762,891 | -62.7% | 323,259 | -0.5% | 0.00% | – |
| Q2 2023 | $2,045,849 | +28.6% | 324,738 | +17.8% | 0.00% | – |
| Q1 2023 | $1,591,182 | -44.4% | 275,768 | -1.2% | 0.00% | -100.0% |
| Q4 2022 | $2,863,874 | -39.6% | 279,130 | -1.6% | 0.00% | 0.0% |
| Q3 2022 | $4,744,000 | +31.3% | 283,695 | +9.9% | 0.00% | 0.0% |
| Q2 2022 | $3,612,000 | +6.0% | 258,022 | +22.3% | 0.00% | 0.0% |
| Q1 2022 | $3,408,000 | -24.9% | 211,034 | -0.5% | 0.00% | 0.0% |
| Q4 2021 | $4,540,000 | +151.7% | 212,015 | +72.6% | 0.00% | – |
| Q3 2021 | $1,804,000 | -33.1% | 122,832 | -9.4% | 0.00% | – |
| Q2 2021 | $2,696,000 | – | 135,527 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 5,364,850 | $78,810,000 | 3.20% |
| Logos Global Management LP | 2,772,501 | $40,728,000 | 2.94% |
| EcoR1 Capital, LLC | 1,863,098 | $27,369,000 | 0.95% |
| RA Capital Management | 2,186,636 | $32,122,000 | 0.44% |
| Vivo Capital, LLC | 530,991 | $7,800,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,468,318 | $21,570,000 | 0.34% |
| Artal Group S.A. | 400,000 | $5,876,000 | 0.13% |
| Rock Springs Capital Management LP | 334,050 | $4,907,000 | 0.10% |
| Baker Brothers Advisors | 1,436,636 | $21,104,000 | 0.09% |
| Eventide Asset Management | 400,000 | $5,876,000 | 0.08% |